Three experts on HCM discuss the difficulty in making the diagnosis of HCM as it encompasses a range of diseases and how testing can help. Furthermore, they present novel potential targets for intervention and trial data of previous trials with cardiac myosin inhibitors and what the future holds on this topic.
Managing hypertrophic cardiomyopathy in clinical practice: The patient journey
3
episodes
0.75 program credits 41m
Details
Documents
Presenters
Comments
Program Highlights
This educational program consists of 3 presentations on hypertrophic cardiomyopathy.
What are the challenges in making the right diagnosis? - Perry Elliott, MD, PhD – London, UK
- “HCM is not a single disorder, it is not even a diagnosis. It is a description that encompasses a range of diseases”, says Perry Elliott.
Understanding the etiology of HCM and pathways for intervention - Roberto Barriales Villa, MD, PhD - A Coruña, Spain
- Roberto Barriales-Villa explains the etiologies and pathophysiology of HCM and how this understanding has resulted in potential targets for intervention.
The Clinical Challenge of Managing a Patient with HCM - Iacopo Olivotto, MD – Florence, Italy
- Iacopo Olivotto presents an overview of stage-specific therapies for HCM and focuses on myosin inhibitors for the treatment of obstructive HCM.
- “HCM is not a single disorder, it is not even a diagnosis. It is a description that encompasses a range of diseases”, says Perry Elliott.
Instructions
- Watch the three lectures and answer the pre- and post-test questions
- Fill in the evaluation questions
- Download CME Certificate
For questions regarding this activity, please contact us at info@pace-cme.org.
Learning Objectives
- Describe the approach of making the differential diagnosis in individuals with suspected HCM
- Identify potential targets for intervention in HCM by understanding the etiologies of this disease
- Interpret trial data on novel myosin inhibitors in HCM and treatment recommendations in guidelines for this patient population
Target Audience
This activity has been designed to meet the educational needs of cardiologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with hypertrophic cardiomyopathy.
Accreditation and Credit Designation Statements
This enduring activity is accredited by the European Board for Accreditation of Continuing Education for Health Professional (EBAC) for 44 minutes of effective education time. Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit(s)™.
Provider(s)/Educational Partner(s)
Today’s healthcare environment is constantly evolving and advances of medical science occur at an accelerating pace. CME/CE plays an important role in the clinical environment and is an essential element of physician training, learning, and improvement, thereby importantly contributing to optimal patient care. Since 2000, MEDCON’s mission is to deliver high quality within the world of medical education by creating forums like PACE-CME, organizing live meetings, and providing online education. We aim to stimulate the review, exchange, and assimilation of key scientific findings to improve patients’ health, to raise awareness of new science underlying various disease states, and to accelerate the translation of this information into clinical practice.
Commercial Support
Supported by an unrestricted educational grant from Bristol-Myers Squibb.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-cme.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
